Effects of serum protein and colloid on the alamarBlue assay in cell cultures.

P. Goegan,G. Johnson,Renaud Vincent

DOI: https://doi.org/10.1016/0887-2333(95)00004-R

IF: 3.685

1995-06-01

Toxicology in Vitro

Abstract:

What problem does this paper attempt to address?

IgNAR characterization and gene loci identification in whitespotted bamboo shark (Chiloscyllium plagiosum) genome

Lei Jia,Yu Wang,Yajun Shen,Bo Zhong,Zhan Luo,Junjie Yang,Guodong Chen,Xiaofeng Jiang,Jianqing Chen,Zhengbing Lyu

DOI: https://doi.org/10.1016/j.fsi.2023.108535

Abstract:Single domain antibodies (sdAb) are promising candidates in cancer and anti-virus biotherapies for their unique structure characters. Though VHH and IgNAR have been discovered in camelidae and nurse shark (Ginlymostoma cirratum) respectively serval decades ago, expense of these large animals still limits the studies and applications of sdAb. Recently, IgNAR has been found in whitespotted bamboo shark (Chiloscyllium plagiosum), a small-sized sharks, while how to characterize and achieved the IgNAR of whitespotted bamboo shark is still unclear. In our research, we identified four IgNAR coding gene loci in whitespotted bamboo shark chromosome 44 (NC_057753.1), and primers were designed for single domain variable regions of IgNAR (VNAR) libraries preparation. Following sequencing results revealed that all plasmids constructed with our predicted VNAR libraries contained VNAR coding sequences, which confirmed the specificities of our primers in VNAR amplification. To our surprise, ≥90% VNAR sequences were encoded by IgNAR1, which suggests IgNAR1 is the most active IgNAR transcription locus in whitespotted bamboo shark. Interestingly, we found IgNAR(ΔC2-C3) were encoded by IgNAR3. Our findings gave a new sight of whitespotted bamboo shark IgNAR, which would broad the way of IgNAR studies and applications in biotherapies.
Characterization and humanization of VNARs targeting human serum albumin from the whitespotted bamboo shark (Chiloscyllium plagiosum)

Weijie Li,Mingliang Chen,Tao Wang,Xin Feng,Xierui Jiang,Xiaoning Dong,Huan Zhang,Xixiang Tang,Rui Tian,Yongyou Zhang,Zengpeng Li

DOI: https://doi.org/10.1016/j.ijbiomac.2024.133082

Abstract:The Shark-derived immunoglobulin new antigen receptors (IgNARs) have gained increasing attention for their high solubility, exceptional thermal stability, and intricate sequence variation. In this study, we immunized whitespotted bamboo shark (Chiloscyllium plagiosum) to create phage display library of variable domains of IgNAR (VNARs) for screening against Human Serum Albumin (HSA), a versatile vehicle in circulation due to its long in vivo half-life. We identified two HSA-binding VNAR clones, 2G5 and 2G6, and enhanced their expression in E. coli with the FKPA chaperone. 2G6 exhibited a strong binding affinity of 13 nM with HSA and an EC50 of 1 nM. In vivo study with a murine model further provided initial validation of 2G6's ability to prolong circulation time by binding to HSA. Additionally, we employed computational molecular docking to predict the binding affinities of both 2G6 and its humanized derivative, H2G6, to HSA. Our analysis unveiled that the complementarity-determining regions (CDR1 and CDR3) are pivotal in the antigen recognition process. Therefore, our study has advanced the understanding of the potential applications of VNARs in biomedical research aimed at extending drug half-life, holding promise for future therapeutic and diagnostic progressions.
Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications

Salma Nassor Juma,Xiaoxia Gong,Sujie Hu,Zhengbing Lv,Jianzhong Shao,Lili Liu,Guiqian Chen

DOI: https://doi.org/10.3390/cells10051140

IF: 6

2021-05-08

Cells

Abstract:Shark is a cartilaginous fish that produces new antigen receptor (IgNAR) antibodies. This antibody is identified with a similar human heavy chain but dissimilar sequences. The variable domain (VNAR) of IgNAR is stable and small in size, these features are desirable for drug discovery. Previous study results revealed the effectiveness of VNAR as a single molecule or a combination molecule to treat diseases both in vivo and in vitro with promising clinical applications. We showed the first evidence of IgNAR alternative splicing from spotted bamboo shark (Chiloscyllium plagiosum), broadening our understanding of the IgNARs characteristics. In this review, we summarize the discoveries on IgNAR with a focus on its advantages for therapeutic development based on its peculiar biochemistry and molecular structure. Proper applications of IgNAR will provide a novel avenue to understand its special presence in cartilaginous fishes as well as designing a number of drugs for undefeated diseases.

cell biology
Sequence structure character of IgNAR Sec in whitespotted bamboo shark (Chiloscyllium plagiosum)

Wenjie Zhang,Lanyi Qin,Xinyi Cai,Salma Nassor Juma,Rong Xu,Ling Wei,Yixin Wu,Xuan Cui,Guiqian Chen,Lili Liu,Zhengbing Lv,Xiaofeng Jiang

DOI: https://doi.org/10.1016/j.fsi.2020.04.037

Abstract:Whitespotted bamboo shark (Chiloscyllium plagiosum) is a demersal cartilaginous fish with an adaptive immune system founded upon immunoglobulins. In this manuscript, we characterize the IgNAR of the whitespotted bamboo shark. A newly discovered alternative splicing form of IgNAR Sec (IgNARshort (ΔC2-C3) Sec) was identified, in which the C1 domain was spliced directly to the C4 domain, the process resulted in a molecule containing three constant domains. However, a single unpaired cysteine remains in the highly flexible hinge region, contributing in the formation of an interchain disulfide bond. Two types of C1 domain were found, and the one lacking a short α-helix showed lower proportion. This finding suggests that short α-helices might be important to the stability of IgNAR. High-throughput sequencing revealed that the percentage of VNAR types significantly vary between the diverse species of sharks. The variable region of IgNAR (the VNAR) with small size and stabilization is a potential candidate for immunotherapeutic agents. The structure and stability analysis in this manuscript may be useful in future biomedical applications.
VNAR development through antigen immunization of Japanese topeshark (Hemitriakis japanica)

Hiroyuki Takeda,Tatsuhiko Ozawa,Hiroki Zenke,Yoh Ohnuki,Yuri Umeda,Wei Zhou,Honoka Tomoda,Akihiko Takechi,Kimiyoshi Narita,Takaaki Shimizu,Takuya Miyakawa,Yuji Ito,Tatsuya Sawasaki

DOI: https://doi.org/10.3389/fbioe.2023.1265582

IF: 5.7

2023-09-13

Frontiers in Bioengineering and Biotechnology

Abstract:The VNAR (Variable New Antigen Receptor) is the smallest single-domain antibody derived from the variable domain of IgNAR of cartilaginous fishes. Despite its biomedical and diagnostic potential, research on VNAR has been limited due to the difficulties in obtaining and maintaining immune animals and the lack of research tools. In this study, we investigated the Japanese topeshark as a promising immune animal for the development of VNAR. This shark is an underutilized fishery resource readily available in East Asia coastal waters and can be safely handled without sharp teeth or venomous stingers. The administration of Venus fluorescent protein to Japanese topesharks markedly increased antigen-specific IgM and IgNAR antibodies in the blood. Both the phage-display library and the yeast-display library were constructed using RNA from immunized shark splenocytes. Each library was enriched by biopanning, and multiple antigen-specific VNARs were acquired. The obtained antibodies had affinities of 1 × 10 −8 M order and showed high plasticity, retaining their binding activity even after high-temperature or reducing-agent treatment. The dissociation rate of a low-affinity VNAR was significantly improved via dimerization. These results demonstrate the potential utility of the Japanese topeshark for the development of VNAR. Furthermore, we conducted deep sequencing analysis to reveal the quantitative changes in the CDR3-coding sequences, revealing distinct enrichment bias between libraries. VNARs that were primarily enriched in the phage display had CDR3 coding sequences with fewer E. coli rare codons, suggesting translation machinery on the selection and enrichment process during biopanning.

multidisciplinary sciences
Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein

Yu-Lei Chen,Jin-Jin Lin,Huan Ma,Ning Zhong,Xin-Xin Xie,Yunru Yang,Peiyi Zheng,Ling-Jing Zhang,Tengchuan Jin,Min-Jie Cao

DOI: https://doi.org/10.3390/ijms231810904

IF: 5.6

2022-09-19

International Journal of Molecular Sciences

Abstract:The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is the major target for antibody therapeutics. Shark-derived variable domains of new antigen receptors (VNARs) are the smallest antibody fragments with flexible paratopes that can recognize protein motifs inaccessible to classical antibodies. This study reported four VNARs binders (JM-2, JM-5, JM-17, and JM-18) isolated from Chiloscyllium plagiosum immunized with SARS-CoV-2 RBD. Biolayer interferometry showed that the VNARs bound to the RBD with an affinity KD ranging from 38.5 to 2720 nM, and their Fc fusions had over ten times improved affinity. Gel filtration chromatography revealed that JM-2-Fc, JM-5-Fc, and JM-18-Fc could form stable complexes with RBD in solution. In addition, five bi-paratopic VNARs, named JM-2-5, JM-2-17, JM-2-18, JM-5-18, and JM-17-18, were constructed by fusing two VNARs targeting distinct RBD epitopes based on epitope grouping results. All these bi-paratopic VNARs except for JM-5-18 showed higher RBD binding affinities than its component VNARs, and their Fc fusions exhibited further enhanced binding affinities, with JM-2-5-Fc, JM-2-17-Fc, JM-2-18-Fc, and JM-5-18-Fc having KD values lower than 1 pM. Among these Fc fusions of bi-paratopic VNARs, JM-2-5-Fc, JM-2-17-Fc, and JM-2-18-Fc could block the angiotensin-converting enzyme 2 (ACE2) binding to the RBD of SARS-CoV-2 wildtype, Delta, Omicron, and SARS-CoV, with inhibition rates of 48.9~84.3%. Therefore, these high-affinity VNAR binders showed promise as detectors and therapeutics of COVID-19.

biochemistry & molecular biology,chemistry, multidisciplinary
Identification of nurse shark VNAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV‐2

Jesse Buffington,Zhijian Duan,Hyung Joon Kwon,Jessica Hong,Dan Li,Mingqian Feng,Hang Xie,Mitchell Ho

DOI: https://doi.org/10.1096/fj.202202099RR

2023-05-18

The FASEB Journal

Abstract:Shark VNAR nanobodies targeting the S2 subunit of SARS‐CoV‐2 spike protein were identified from a naïve nurse shark VNAR phage display library by phage panning. The S2A9 VNAR showed the best neutralization activity against the original pseudotyped virus and was further characterized. S2A9 had broad neutralization activity against different variants in both pseudovirus and live virus neutralization assays. Our results indicate that S2A9 could be a promising lead molecule in developing broadly neutralizing antibodies against SARS‐CoV‐2 and emerging variants. SARS‐CoV‐2 is the etiological agent of the COVID‐19 pandemic. Antibody‐based therapeutics targeting the spike protein, specifically the S1 subunit or the receptor binding domain (RBD) of SARS‐CoV‐2, have gained attention due to their clinical efficacy in treating patients diagnosed with COVID‐19. An alternative to conventional antibody therapeutics is the use of shark new antigen variable receptor domain (VNAR) antibodies. VNARs are small (<15 kDa) and can reach deep into the pockets or grooves of the target antigen. Here, we have isolated 53 VNARs that bind to the S2 subunit by phage panning from a naïve nurse shark VNAR phage display library constructed in our laboratory. Among those binders, S2A9 showed the best neutralization activity against the original pseudotyped SARS‐CoV‐2 virus. Several binders, including S2A9, showed cross‐reactivity against S2 subunits from other β coronaviruses. Furthermore, S2A9 showed neutralization activity against all variants of concern (VOCs) from alpha to omicron (including BA1, BA2, BA4, and BA5) in both pseudovirus and live virus neutralization assays. Our findings suggest that S2A9 could be a promising lead molecule for the development of broadly neutralizing antibodies against SARS‐CoV‐2 and emerging variants. The nurse shark VNAR phage library offers a novel platform that can be used to rapidly isolate single‐domain antibodies against emerging viral pathogens.
Specific Ligands for Classical Swine Fever Virus Screened from Landscape Phage Display Library.

Long Yin,Yuzi Luo,Bo Liang,Fei Wang,Min Du,Valery A Petrenko,Hua-Ji Qiu,Aihua Liu

DOI: https://doi.org/10.1016/j.antiviral.2014.06.012

IF: 7.6

2014-01-01

Antiviral Research

Abstract:Classical swine fever (CSF) is a devastating infectious disease caused by classical swine fever virus (CSFV). The screening of CSFV-specific ligands is of great significance for diagnosis and treatment of CSF. Affinity selection from random peptide libraries is an efficient approach to discover ligands with high stability and specificity. Here, we screened phage ligands for the CSFV E2 protein from f8/8 landscape phage display library by biopanning and obtained four phage clones specific for the E2 protein of CSFV. Viral blocking assays indicated that the phage clone displaying the octapeptide sequence DRATSSNA remarkably inhibited the CSFV replication in PK-15 cells at a titer of 10(10) transduction units, as evidenced by significantly decreased viral RNA copies and viral titers. The phage-displayed E2-binding peptides have the potential to be developed as antivirals for CSF.
Characterization of luciferases and its paralogue in the Panamanian luminous click beetle Pyrophorus angustus: a click beetle luciferase lacks the fatty acyl-CoA synthetic activity.

Y. Oba,Mizuho Kumazaki,S. Inouye

DOI: https://doi.org/10.1016/j.gene.2009.12.001

IF: 3.913

2010-02-15

Gene

Abstract:
Ant Colony System for the Design of Combinational Logic Circuits

C. C. Coello,R. Gutierrez,B. M. García,A. H. Aguirre

DOI: https://doi.org/10.1007/3-540-46406-9_3

2000-04-17

Abstract:
To the editor: Simple method to distinguish the epidermal side in suction-blistered epidermal grafting using a magnifying lens.

Y. Choi,Kwang-Jun Lee,Won-Serk Kim,Joo-Heung Lee,Jun-Mo Yang,Eil‐Soo Lee,Dong-Youn Lee

DOI: https://doi.org/10.1111/J.1524-4725.2005.31225

2005-10-01

Dermatologic Surgery

Abstract:
[Major esophageal involvement in the course of acute disseminated lupus erythematosus].

J. Ferroir,J. Saraux,B. Tubiana,J. Cocheton

1980-09-20

Abstract:
Development of Shark Single Domain Antibodies Specific for Human α-Fetoprotein and the Multimerization Strategy in Serum Detection

Zheming Wang,Xiaoxia Xie,Zhenyun He,Zhichang Sun,Yongli Zhang,Fujing Mao,Hua Pei,Sihang Zhang,Bruce D Hammock,Xing Liu

DOI: https://doi.org/10.1021/acs.analchem.3c05675

2024-03-12

Abstract:Sensitive detection of cancer biomarkers can contribute to the timely diagnosis and treatment of diseases. In this study, the whitespotted bamboo sharks were immunized with human α-fetoprotein (AFP), and a phage-displayed variable new antigen receptor (VNAR) single domain antibody library was constructed. Then four unique VNARs (VNAR1, VNAR11, VNAR21, and VNAR25) against AFP were isolated from the library by biopanning for the first time. All of the sequences belong to type II of VNAR, and the VNAR11 was much different from the rest of the three sequences. Then VNAR1 and VNAR11 were selected to fuse with the C4-binding protein α chain (C4bpα) sequence and efficiently expressed in the Escherichia coli system. Furthermore, a VNAR-C4bpα-mediated sandwich chemiluminescence immunoassay (VSCLIA) was developed for the detection of AFP in human serum samples. After optimization, the VSCLIA showed a limit of detection of 0.74 ng/mL with good selectivity and accuracy. Moreover, the results of clinical serum samples detected by the VSCLIA were confirmed by an automatic immunoanalyzer in the hospital, indicating its practical application in actual samples. In conclusion, the novel antibody element VNAR exhibits great potential for immunodiagnosis, and this study also provides a new direction and experimental basis for AFP detection.
1H, 13C and 15N resonance assignments of a shark variable new antigen receptor against hyaluronan synthase

Yuxin Liu,Hao Wang,Cookson K C Chiu,Yujie Wu,Yunchen Bi

DOI: https://doi.org/10.1007/s12104-024-10190-6

Abstract:Single domain antibody (sdAb) is only composed of a variable domain of the heavy-chain-only antibody, which is devoid of light chain and naturally occurring in camelids and cartilaginous fishes. Variable New Antigen Receptor (VNAR), a type of single domain antibody present in cartilaginous fishes such as sharks, is the smallest functional antigen-binding fragment found in nature. The unique features, including flexible paratope, high solubility and outstanding stability make VNAR a promising prospect in antibody drug development and structural biology research. However, VNAR's research has lagged behind camelid-derived sdAb, especially in the field of structural research. Here we report the 1H,15N,13C resonance assignments of a VNAR derived from the immune library of Chiloscyllium plagiosum, termed B2-3, which recognizes the hyaluronan synthase. Analysis of the backbone chemical shifts demonstrates that the secondary structure of VNAR is predominately composed of β-sheets corresponding to around 40% of the B2-3 backbone. The Cβ chemical shift values of cysteine residues, combined with mass spectrometry data, clearly shows that B2-3 contains two pairs of disulfide bonds, which is import for protein stability. The assignments will be essential for determining the high resolution solution structure of B2-3 by NMR spectroscopy.
Shark IgNAR-derived binding domains as potential diagnostic and therapeutic agents

Hanover Matz,Helen Dooley

DOI: https://doi.org/10.1016/j.dci.2018.09.007

Abstract:Many of the most successful drugs generated in recent years are based upon monoclonal antibodies (mAbs). However, for some therapeutic and diagnostic applications mAbs are far from ideal; for example, while their relatively large size and inherent receptor binding aids their longevity in vivo it can also limit their tissue penetration. Further, their structural complexity makes them expensive to produce and prone to denaturation in non-physiological environments. Thus, researchers have been searching for alternative antigen-binding molecules that can be utilized in situations where mAbs are suboptimal tools. One potential source currently being explored are the shark-derived binding domains known as VNARs. Despite their small size VNARs can bind antigens with high specificity and high affinity. Combined with their propensity to bind epitopes that are inaccessible to conventional mAbs, and their ability to resist denaturation, VNARs are an emerging prospect for use in therapeutic, diagnostic, and biotechnological applications.
Shark IgNAR: The Next Broad Application Antibody in Clinical Diagnoses and Tumor Therapies?

Xiaofeng Jiang,Ling Sun,Chengwu Hu,Feijian Zheng,Zhengbing Lyu,Jianzhong Shao

DOI: https://doi.org/10.3390/md21090496

2023-09-17

Marine Drugs

Abstract:Antibodies represent a relatively mature detection means and serve as therapeutic drug carriers in the clinical diagnosis and treatment of cancer—among which monoclonal antibodies (mAbs) currently occupy a dominant position. However, the emergence and development of small-molecule monodomain antibodies are inevitable due to the many limitations of mAbs, such as their large size, complex structure, and sensitivity to extreme temperature, and tumor microenvironments. Thus, since first discovered in Chondroid fish in 1995, IgNAR has become an alternative therapeutic strategy through which to replace monoclonal antibodies, thus entailing that this novel type of immunoglobulin has received wide attention with respect to clinical diagnoses and tumor therapies. The variable new antigen receptor (VNAR) of IgNAR provides an advantage for the development of new antitumor drugs due to its small size, high stability, high affinity, as well as other structural and functional characteristics. In that respect, a better understanding of the unique characteristics and therapeutic potential of IgNAR/VNAR in clinical and anti-tumor treatment is needed. This article reviews the advantages of its unique biochemical conditions and molecular structure for clinical diagnoses and novel anti-tumor drugs. At the same time, the main advantages of the existing conjugated drugs, which are based on single-domain antibodies, are introduced here, thereby providing new ideas and methods for the development of clinical diagnoses and anti-tumor therapies in the future.

pharmacology & pharmacy,chemistry, medicinal
Characteristics and Genomic Localization of Nurse Shark (Ginglymostoma cirratum) IgNAR

Wenjie Tang,Kaixi Zheng,Shengjie Sun,Bo Zhong,Zhan Luo,Junjie Yang,Lei Jia,Lan Yang,Wenna Shang,Xiaofeng Jiang,Zhengbing Lyu,Jianqing Chen,Guodong Chen

DOI: https://doi.org/10.3390/ijms252312879

IF: 5.6

2024-11-30

International Journal of Molecular Sciences

Abstract:The variable domain of IgNAR shows great potential in biological medicine and therapy. IgNAR has been discovered in sharks and rays, with the nurse shark (Ginglymostoma cirratum) IgNARs being the most extensively studied among sharks. Despite being identified in nurse sharks over 30 years ago, the characteristics and genomic localization of IgNAR remain poorly defined, with significant gaps even in the latest released genome data. In our research, we localized the IgNAR loci in the nurse shark genome and resolved the previously missing regions. We identified three IgNAR loci, designated GcIgNAR1, GcIgNAR2, and GcIgNAR3, with only GcIgNAR1 and GcIgNAR2 being expressed. GcIgNAR1 and GcIgNAR2 belong to type I and type II IgNARs, respectively, and each exhibits several different isoforms. Most nurse shark IgNARs possess five constant domains. However, we found transcripts of GcIgNAR1 and GcIgNAR2 lacking two constant domains, C4 and C5, which differ from the IgNAR of the whitespotted bamboo shark. The protein structures of GcIgNAR1 and GcIgNAR2, generated by AlphaFold3, confirmed the accuracy of the IgNAR loci we identified. Our findings advance scientific understanding of IgNAR in nurse sharks and facilitate future research and medical applications.

biochemistry & molecular biology,chemistry, multidisciplinary
A Nucleic Acid Triple Helix Formed by a Peptide Nucleic Acid-DNA Complex

L. Betts,J. Josey,J. Veal,S. Jordan

DOI: https://doi.org/10.1126/science.270.5243.1838

IF: 56.9

1995-12-15

Science

Abstract:The crystal structure of a nucleic acid triplex reveals a helix, designated P-form, that differs from previously reported nucleic acid structures. The triplex consists of one polypurine DNA strand complexed to a polypyrimidine hairpin peptide nucleic acid (PNA) and was successfully designed to promote Watson-Crick and Hoogsteen base pairing. The P-form helix is underwound, with a base tilt similar to B-form DNA. The bases are displaced from the helix axis even more than in A-form DNA. Hydrogen bonds between the DNA backbone and the Hoogsteen PNA backbone explain the observation that polypyrimidine PNA sequences form highly stable 21 PNA-DNA complexes. This structure expands the number of known stable helical forms that nucleic acids can adopt.
Vector and tensor polarization lifetimes for a stored deuteron beam.

B. Przewoski,V. Anferov,H. Meyer,P. Schwandt,E. Stephenson,V. Morozov,Z. Etienne,M. Kandes,M. Leonova,D. Sivers,K. Yonehara

DOI: https://doi.org/10.1103/PHYSREVE.68.046501

2003-10-01

Abstract:The time dependence of the vector and tensor polarization of a 270 MeV stored deuteron beam was measured near a depolarizing resonance, which was induced by an oscillating, longitudinal magnetic field. The distance to the resonance was varied by changing the oscillation frequency. The measured ratio of the polarization lifetimes is tau(vector)/tau(tensor)=1.9+/-0.2. Assuming that the effect of the resonance is to induce transitions between magnetic substates m(I), we find that the transition rate between neighboring states (+1 and 0 or -1 and 0) is four times higher than between the states with m(I)=+1 and -1.
Inhibition of brain monoamine oxidase.

A. Davison

Abstract:

Effects of serum protein and colloid on the alamarBlue assay in cell cultures.

IgNAR characterization and gene loci identification in whitespotted bamboo shark (Chiloscyllium plagiosum) genome

Characterization and humanization of VNARs targeting human serum albumin from the whitespotted bamboo shark (Chiloscyllium plagiosum)

Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications

Sequence structure character of IgNAR Sec in whitespotted bamboo shark (Chiloscyllium plagiosum)

VNAR development through antigen immunization of Japanese topeshark (Hemitriakis japanica)

Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein

Identification of nurse shark VNAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV‐2

Specific Ligands for Classical Swine Fever Virus Screened from Landscape Phage Display Library.

Characterization of luciferases and its paralogue in the Panamanian luminous click beetle Pyrophorus angustus: a click beetle luciferase lacks the fatty acyl-CoA synthetic activity.

Ant Colony System for the Design of Combinational Logic Circuits

To the editor: Simple method to distinguish the epidermal side in suction-blistered epidermal grafting using a magnifying lens.

[Major esophageal involvement in the course of acute disseminated lupus erythematosus].

Development of Shark Single Domain Antibodies Specific for Human α-Fetoprotein and the Multimerization Strategy in Serum Detection

1H, 13C and 15N resonance assignments of a shark variable new antigen receptor against hyaluronan synthase

Shark IgNAR-derived binding domains as potential diagnostic and therapeutic agents

Shark IgNAR: The Next Broad Application Antibody in Clinical Diagnoses and Tumor Therapies?

Characteristics and Genomic Localization of Nurse Shark (Ginglymostoma cirratum) IgNAR

A Nucleic Acid Triple Helix Formed by a Peptide Nucleic Acid-DNA Complex

Vector and tensor polarization lifetimes for a stored deuteron beam.

Inhibition of brain monoamine oxidase.